These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24112080)

  • 1. Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function.
    Yilmaz MI; Sonmez A; Saglam M; Yaman H; Unal HU; Gok M; Cetinkaya H; Eyileten T; Oguz Y; Sari S; Yildirim AO; Vural A; Carrero JJ; Blanco-Colio LM
    Eur J Clin Invest; 2013 Dec; 43(12):1250-7. PubMed ID: 24112080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.
    Yilmaz MI; Sonmez A; Ortiz A; Saglam M; Kilic S; Eyileten T; Caglar K; Oguz Y; Vural A; Çakar M; Egido J; Altun B; Yenicesu M; Blanco-Colio LM; Carrero JJ
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):785-92. PubMed ID: 21330486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease.
    Yilmaz MI; Carrero JJ; Ortiz A; Martín-Ventura JL; Sonmez A; Saglam M; Yaman H; Yenicesu M; Egido J; Blanco-Colio LM
    Clin J Am Soc Nephrol; 2009 Nov; 4(11):1716-23. PubMed ID: 19820131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease.
    Valdivielso JM; Coll B; Martín-Ventura JL; Moreno JA; Egido J; Fernández E; Blanco-Colio LM
    J Nephrol; 2013; 26(6):1105-13. PubMed ID: 23475462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.
    Yilmaz MI; Saglam M; Caglar K; Cakir E; Sonmez A; Ozgurtas T; Aydin A; Eyileten T; Ozcan O; Acikel C; Tasar M; Genctoy G; Erbil K; Vural A; Zoccali C
    Am J Kidney Dis; 2006 Jan; 47(1):42-50. PubMed ID: 16377384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum asymmetric dimethylarginine and endothelial function after renal transplantation.
    Zhang W; Zhou C; Xie J; Chen B; Chang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 34(4):289-94. PubMed ID: 19411743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk.
    Ardigo D; Stüehlinger M; Franzini L; Valtueña S; Piatti PM; Pachinger O; Reaven GM; Zavaroni I
    Eur J Clin Invest; 2007 Apr; 37(4):263-9. PubMed ID: 17373961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
    Gates PE; Boucher ML; Silver AE; Monahan KD; Seals DR
    J Appl Physiol (1985); 2007 Jan; 102(1):63-71. PubMed ID: 16946027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soy protein diet improves endothelial dysfunction in renal transplant patients.
    Cupisti A; Ghiadoni L; D'Alessandro C; Kardasz I; Morelli E; Panichi V; Locati D; Morandi S; Saba A; Barsotti G; Taddei S; Arnoldi A; Salvetti A
    Nephrol Dial Transplant; 2007 Jan; 22(1):229-34. PubMed ID: 16998212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease.
    Chen J; Hamm LL; Mohler ER; Hudaihed A; Arora R; Chen CS; Liu Y; Browne G; Mills KT; Kleinpeter MA; Simon EE; Rifai N; Klag MJ; He J
    PLoS One; 2015; 10(7):e0132047. PubMed ID: 26132137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction in renal transplant recipients: role of vitamin D and fibroblast growth factor-23.
    Yildirim T; Yilmaz R; Altindal M; Turkmen E; Arici M; Altun B; Erdem Y
    Transplant Proc; 2015 Mar; 47(2):343-7. PubMed ID: 25769570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation.
    Yilmaz MI; Saglam M; Caglar K; Cakir E; Ozgurtas T; Sonmez A; Eyileten T; Yenicesu M; Acikel C; Oguz Y; Ozcan O; Bozlar U; Erbil K; Aslan I; Vural A
    Transplantation; 2005 Dec; 80(12):1660-6. PubMed ID: 16378057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of endothelial dysfunction in Asian Indian patients with chronic kidney disease and changes following renal transplantation.
    Sharma J; Kapoor A; Muthu R; Prasad N; Sinha A; Khanna R; Kumar S; Garg N; Tewari S; Sharma RK; Goel P
    Clin Transplant; 2014 Aug; 28(8):889-96. PubMed ID: 24930933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtle changes in ADMA and l-arginine concentrations in normal pregnancies are unlikely to account for pregnancy-related increased flow-mediated dilatation.
    Saarelainen H; Valtonen P; Punnonen K; Laitinen T; Raitakari OT; Juonala M; Heiskanen N; Lyyra-Laitinen T; Viikari JS; Vanninen E; Heinonen S
    Clin Physiol Funct Imaging; 2008 Mar; 28(2):120-4. PubMed ID: 18093231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome.
    Soyman Z; Noyan V; Tulmac M; Yucel A; Sagsoz N; Bayrak T; Bayrak A; Cakir E
    Fertil Steril; 2011 Mar; 95(3):1067-72. PubMed ID: 21193188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study.
    Juonala M; Viikari JS; Alfthan G; Marniemi J; Kähönen M; Taittonen L; Laitinen T; Raitakari OT
    Circulation; 2007 Sep; 116(12):1367-73. PubMed ID: 17724260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L; Ingelsson E; Kumar J; Syvänen AC; Axelsson T; Teerlink T
    Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxide synthase.
    Yasuda S; Miyazaki S; Kanda M; Goto Y; Suzuki M; Harano Y; Nonogi H
    Eur Heart J; 2006 May; 27(10):1159-65. PubMed ID: 16627554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble TWEAK level: is it a marker for cardiovascular disease in long-term hemodialysis patients?
    Gungor O; Kircelli F; Asci G; Carrero JJ; Tatar E; Demirci MS; Ozbek SS; Ceylan N; Toz H; Ozkahya M; Ok E
    J Nephrol; 2013; 26(1):136-43. PubMed ID: 22505251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia.
    Vladimirova-Kitova L; Deneva T; Angelova E; Nikolov F; Marinov B; Mateva N
    Clin Physiol Funct Imaging; 2008 Nov; 28(6):417-25. PubMed ID: 18798847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.